Vijaya Diagnostic Centre Limited reported a landmark year for FY26, with revenues crossing ₹8,142 million. This growth was driven by sustained demand for diagnostic services, increased adoption of preventive healthcare, and strong operational execution. The company also expanded its network, opening 10 hub centers across four geographies. EBITDA increased to ₹3,369 million with a healthy margin of 41.4%, and Profit After Tax stood at ₹1,730 million. The company highlighted its continued focus on technology and customer-centric services as key drivers for future growth.
Robust Financial Performance in FY26
Vijaya Diagnostic Centre Limited has announced a strong financial performance for the fiscal year 2025-26, with revenues reaching ₹8,142 million, marking a significant growth of 19.5% over the previous year. The company’s EBITDA also saw a substantial increase, reaching ₹3,369 million, with an improved EBITDA margin of 41.4%. Profit After Tax (PAT) stood at ₹1,730 million, representing a healthy margin of 21.2%. This performance underscores the company’s integrated diagnostics model and disciplined expansion approach.
Strategic Expansion and Growth
The company executed its most ambitious network expansion program in FY26, commissioning 10 hub centers across four geographies. This expansion was particularly significant in Tier-2 districts of West Bengal, bringing high-quality integrated diagnostics closer to underserved communities. The company also noted the successful launch of its flagship hub in Bengaluru, a facility spanning over 10,000 sq. ft., which houses advanced radiology equipment and a comprehensive pathology laboratory, setting a new benchmark for integrated diagnostics in the region.
Key Business Drivers and Future Outlook
Vijaya Diagnostic Centre attributed its growth to sustained demand for diagnostic services, higher preventive healthcare adoption, and strong operational execution. The B2C segment remained the cornerstone of its business, contributing approximately 92% of total revenues. Looking ahead, the company plans to commission 8-9 hub centers and 10-12 spoke centers in FY27, further deepening its presence in key markets like Pune and West Bengal, and expanding into new geographies. The company remains focused on technology and innovation, including investments in AI-enabled radiology solutions and digital platforms, to enhance patient experience and improve clinical productivity.
Source: BSE
